Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision indicator updated from Revision: v3.4.2 to Revision: v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Generalized pustular psoriasis as a condition reference and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This is a routine platform update with no evident changes to the study information.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No changes to study content or navigation are evident.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now shows a glossary toggle and adds metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data. Versioning was updated from Revision: v3.3.4 to v3.4.0 and some legacy labels were removed, reflecting labeling/UI updates rather than substantive data changes.SummaryDifference0.3%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.